Effects of α-difluoromethylornithine on thrombospondin-1 production by human breast cancer cells

International Journal of Oncology

Volumn 31, Issue 5, 2007, Pages 1187-1191

  Manni, Andrea ^a   Rager, Terry ^a   Kimball, Scot R ^a   Jefferson, Leonard S ^a   Washington, Sharlene ^a   Hu, Xin ^a   Verderame, Michael F ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

difluoromethylornithine; Breast cancer cells; Polyamines; Thrombospondin 1

Indexed keywords

ANTINEOPLASTIC AGENT; EFLORNITHINE; ENZYME INHIBITOR; MESSENGER RNA; THROMBOSPONDIN 1;

ANIMAL; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; EFLORNITHINE; ENZYME INHIBITORS; FEMALE; HUMANS; MICE; RNA, MESSENGER; THROMBOSPONDIN 1;

EID: 38449096130     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Manni A, Washington S, Griffith JW, Verderame MF, Mauger D, Demers LM, Samant RS and Welch DR: Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells. Clin Exp Metastasis 19: 95-105, 2002.
2. Manni A, Hu XWS, Griffith JW, Bruggeman R, Demers LM, Mauger D and Verderame MF: Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells. Clin Exp Metastasis 22: 255-263, 2005.
3. Richert MMPP, Matters G, Digirolamo DJ, Washington S, Demers LM, Bond JS, Manni A and Welch DR: Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment. Breast Cancer Res 7: R819-R827, 2005.
4. Hu XWS, Verderame MF and Manni A: Interaction between polyamines and the MAPK pathway in the regulation of cell cycle parameters in breast cancer cells. Cancer Res 65: 11026-11033, 2005.
5. Manni A, Washington S, Mauger D, Hackett DA and Verderame MF: Cellular mechanisms mediating the antiinvasive properties of the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) in human breast cancer cells. Clin Exp Metastasis 21: 461-467, 2004.
6. Yang QW, Liu S, Tian Y, Salwen HR, Chlenski A, Weinstein J and Cohn SL: Methylation-associated silencing of the thrombospondin- 1 gene in human neuroblastoma. Cancer Res 63: 6299-6310, 2003.
7. Manni A: Influence of polyamines on breast cancer biology. In: Polyamine Cell Signaling: Physiology, Pharmacology, and Cancer Research. Wang J-Y and Casero RA (eds). Humana Press, Totowa, NJ, pp139-153, 2006.
8. Glikman P, Vegh I, Pollina MA, Mosto AH and Levy CM: Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer 60: 2237-2243, 1987.
9. Canizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P and Penafiel R: Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clin Cancer Res 5: 2035-2041, 1999.
10. Manni A, Mauger D, Gimotty P and Badger B: Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Cancer Res 2: 1901-1906, 1996.
11. Zabrenetzky V, Harris CC, Steeg PS and Roberts DD: Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59: 191-195, 1994.
12. Weinstat-Saslow DL, Zabrenetzky VS, van Houtte K, Frazier WA, Roberts DD and Steeg PS: Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54: 6504-6511, 1994.
13. Rice AJ, Steward MA and Quinn CM: Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast. J Clin Pathol 55: 921-925, 2002.